Extended Access Program and Retrospective Chart Review for Lorcaserin in Dravet Syndrome and Other Refractory Epilepsies
Latest Information Update: 13 Jul 2020
At a glance
- Drugs Lorcaserin (Primary)
- Indications Dravet syndrome; Epilepsy
- Focus Expanded access; Therapeutic Use
- Acronyms MOMENTUM 2
- Sponsors Eisai Inc
- 09 Jul 2020 New trial record
- 08 Jul 2020 Status changed from suspended to recruiting.